Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mini-Allogeneic PBPC Transplantation for Breast Cancer
NCT00429572Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 1998
- Primary completion
- May 2008
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of allogeneic hematopoietic stem cells in breast cancer, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoints: Number of Participants With Tumor Response at 24 months, Overall Survival and 3 more. Started Jan 1998; status: completed.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00429572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429572.